Novartis Investigative Site

Muang 40002

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Breast Cancer

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. — Completed